Autoimmune post–herpes simplex encephalitis of adults and teenagers
Open Access
- 17 November 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 85 (20), 1736-1743
- https://doi.org/10.1212/wnl.0000000000002125
Abstract
Objective: To report 14 patients with immune-mediated relapsing symptoms post–herpes simplex encephalitis (HSE) and to compare the clinical and immunologic features of the teenage and adult group with those of young children. Methods: Prospective observational study of patients diagnosed between June 2013 and February 2015. Immunologic techniques have been reported previously. Results: Among the teenage and adult group (8 patients, median age 40 years, range 13–69; 5 male), 3 had an acute symptom presentation suggesting a viral relapse, and 5 a presentation contiguous with HSE suggesting a recrudescence of previous deficits. Seven patients developed severe psychiatric/behavioral symptoms disrupting all social interactions, and one refractory status epilepticus. Blepharospasm occurred in one patient. Five patients had CSF antibodies against NMDA receptor (NMDAR) and 3 against unknown neuronal cell surface proteins. In 5/6 patients, the brain MRI showed new areas of contrast enhancement that decreased after immunotherapy and clinical improvement. Immunotherapy was useful in 7/7 patients, sometimes with impressive recoveries, returning to their baseline HSE residual deficits. Compared with the 6 younger children (median age 13 months, range 6–20, all with NMDAR antibodies), the teenagers and adults were less likely to develop choreoathetosis (0/8 vs 6/6, p < 0.01) and decreased level of consciousness (2/8 vs 6/6, p < 0.01) and had longer delays in diagnosis and treatment (interval relapse/antibody testing 85 days, range 17–296, vs 4 days, range 0–33, p = 0.037). Conclusion: In teenagers and adults, the immune-mediated relapsing syndrome post-HSE is different from that known in young children as choreoathetosis post-HSE and is underrecognized. Prompt diagnosis is important because immunotherapy can be highly effective.This publication has 21 references indexed in Scilit:
- Herpes simplex virus–1 encephalitis can trigger anti-NMDA receptor encephalitis: Case reportNeurology, 2013
- Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N‐Methyl‐D‐aspartate receptor or dopamine‐2 receptorMovement Disorders, 2013
- N‐methyl‐D‐aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapseMovement Disorders, 2013
- Pediatric Herpes Simplex Virus EncephalitisJournal of Child Neurology, 2013
- Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disordersBrain, 2012
- N‐methyl‐D‐aspartate receptor antibodies in herpes simplex encephalitisAnnals of Neurology, 2012
- Cellular and Synaptic Mechanisms of Anti-NMDA Receptor EncephalitisJournal of Neuroscience, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adultsZeitschrift für Neurologie, 2005
- Relapse of Herpes Simplex EncephalitisNeuropediatrics, 1987